Nexium Capsules Clinical Experience Investigation
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2017
At a glance
- Drugs Esomeprazole (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Gastro-oesophageal reflux; Postoperative complications; Reflux oesophagitis; Zollinger-Ellison syndrome
- Focus Adverse reactions
- Sponsors AstraZeneca
- 27 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014as reported by ClinicalTrials.gov.
- 08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.